Holdings of Tema Oncology ETF
Tema ETF Trust ·55 declared positions · as of Feb 28, 2026
Original filing · Net assets 159.9M $ · Ten largest lines: 44.1 % of the equity sleeve
Sector breakdown
- Health care 36.7 %
- Unattributed 63.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 89.1 %
- CHF 5.0 %
- GBP 4.7 %
- JPY 1.3 %
The quoted currency of each line, as declared.
Country breakdown
- US 77.6 %
- CH 9.1 %
- GB 4.7 %
- KY 3.4 %
- DK 3.1 %
- JP 1.3 %
- NL 0.8 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 46 | 123.2M $ | 77.61 % |
| 2 | CH | 2 | 14.4M $ | 9.08 % |
| 3 | GB | 1 | 7.4M $ | 4.66 % |
| 4 | KY | 3 | 5.4M $ | 3.41 % |
| 5 | DK | 1 | 5M $ | 3.15 % |
| 6 | JP | 1 | 2.1M $ | 1.29 % |
| 7 | NL | 1 | 1.3M $ | 0.80 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Revolution Medicines Inc | 98,581 | 10.1M $ | 6.29 % |
| 2 | Novartis AG | 46,684 | 7.9M $ | 4.96 % |
| 3 | Bridgebio Pharma Inc | 114,318 | 7.6M $ | 4.75 % |
| 4 | AstraZeneca PLC | 35,320 | 7.4M $ | 4.63 % |
| 5 | Eli Lilly & Co | 6,565 | 6.9M $ | 4.32 % |
| 6 | Bristol-Myers Squibb Co | 108,187 | 6.7M $ | 4.22 % |
| 7 | Roche Holding AG | 108,952 | 6.5M $ | 4.06 % |
| 8 | Merck & Co Inc | 49,630 | 6.1M $ | 3.84 % |
| 9 | Arcellx Inc | 48,346 | 5.5M $ | 3.44 % |
| 10 | Cogent Biosciences Inc | 135,358 | 5.3M $ | 3.29 % |
| 11 | Nuvalent Inc | 49,239 | 5M $ | 3.14 % |
| 12 | Genmab A/S | 169,724 | 5M $ | 3.13 % |
| 13 | Immunome Inc | 195,451 | 4.3M $ | 2.67 % |
| 14 | Johnson & Johnson | 16,257 | 4M $ | 2.53 % |
| 15 | Celcuity Inc | 35,371 | 4M $ | 2.47 % |
| 16 | Amgen Inc | 10,122 | 3.9M $ | 2.46 % |
| 17 | AbbVie Inc | 16,712 | 3.9M $ | 2.43 % |
| 18 | Exelixis Inc | 79,639 | 3.5M $ | 2.19 % |
| 19 | Ideaya Biosciences Inc | 89,238 | 2.9M $ | 1.80 % |
| 20 | BEONE MEDICINES LTD | 8,960 | 2.8M $ | 1.78 % |
| 21 | Syndax Pharmaceuticals Inc | 127,353 | 2.8M $ | 1.73 % |
| 22 | CG oncology Inc | 45,885 | 2.7M $ | 1.69 % |
| 23 | ZAI LAB LTD | 121,279 | 2.3M $ | 1.46 % |
| 24 | Erasca Inc | 169,487 | 2.3M $ | 1.45 % |
| 25 | Zymeworks Inc | 96,723 | 2.3M $ | 1.41 % |
| 26 | LEGEND BIOTECH CORP | 115,409 | 2.2M $ | 1.37 % |
| 27 | Nuvation Bio Inc | 362,046 | 2.1M $ | 1.34 % |
| 28 | Halozyme Therapeutics Inc | 29,868 | 2.1M $ | 1.30 % |
| 29 | Chugai Pharmaceutical Co Ltd | 30,652 | 2.1M $ | 1.28 % |
| 30 | Summit Therapeutics Inc | 110,918 | 1.8M $ | 1.15 % |
| 31 | AnaptysBio Inc | 28,657 | 1.6M $ | 0.99 % |
| 32 | Nurix Therapeutics Inc | 97,555 | 1.6M $ | 0.97 % |
| 33 | Regeneron Pharmaceuticals, Inc. | 1,982 | 1.5M $ | 0.97 % |
| 34 | Corvus Pharmaceuticals Inc | 82,148 | 1.5M $ | 0.94 % |
| 35 | UroGen Pharma Ltd | 67,164 | 1.5M $ | 0.91 % |
| 36 | Relay Therapeutics Inc | 142,040 | 1.5M $ | 0.91 % |
| 37 | Gilead Sciences Inc | 9,272 | 1.4M $ | 0.86 % |
| 38 | Olema Pharmaceuticals Inc | 56,608 | 1.4M $ | 0.86 % |
| 39 | Day One Biopharmaceuticals Inc | 121,928 | 1.3M $ | 0.81 % |
| 40 | Argenx SE | 1,663 | 1.3M $ | 0.80 % |
| 41 | Terns Pharmaceuticals Inc | 28,018 | 1.2M $ | 0.74 % |
| 42 | Xencor Inc | 76,928 | 982.4K $ | 0.61 % |
| 43 | Tyra Biosciences Inc | 28,438 | 947.3K $ | 0.59 % |
| 44 | Guardant Health Inc | 10,008 | 939.8K $ | 0.59 % |
| 45 | Arcus Biosciences Inc | 45,953 | 936.1K $ | 0.59 % |
| 46 | ArriVent Biopharma Inc | 40,743 | 935.9K $ | 0.59 % |
| 47 | Immunocore Holdings PLC | 28,275 | 913.3K $ | 0.57 % |
| 48 | HUTCHMED China Ltd | 62,129 | 890.3K $ | 0.56 % |
| 49 | Monte Rosa Therapeutics Inc | 45,524 | 808.1K $ | 0.51 % |
| 50 | Cullinan Therapeutics Inc | 47,065 | 729.5K $ | 0.46 % |
| 51 | Compass Therapeutics Inc | 127,476 | 720.2K $ | 0.45 % |
| 52 | Janux Therapeutics Inc | 47,193 | 642.3K $ | 0.40 % |
| 53 | Natera Inc | 3,049 | 634.3K $ | 0.40 % |
| 54 | Arvinas Inc | 45,326 | 601.5K $ | 0.38 % |
| 55 | ORIC Pharmaceuticals Inc | 35,407 | 476.2K $ | 0.30 % |